Cardiovascular Revascularization Medicine
Volume 6, Issue 1 , Pages 14-20 , January 2005

Potential of an intracardiac electrogram for the rapid detection of coronary artery occlusion

  • Tim A. Fischell

      Affiliations

    • Borgess Heart Institute, Kalamazoo, MI 49048, USA
    • Corresponding Author InformationCorresponding author. Department of Medicine, Heart Institute at Borgess Medical Center, Michigan State University, 1521 Gull Road, Kalamazoo, MI 49048, USA. Tel.: +1 269 226 8362; fax: +1 269 226 8349.
  • ,
  • David R. Fischell

      Affiliations

    • Angel Medical Systems, Inc., Tinton Falls, NJ 07701, USA
  • ,
  • Robert E. Fischell

      Affiliations

    • Angel Medical Systems, Inc., Tinton Falls, NJ 07701, USA
  • ,
  • Susan Baskerville

      Affiliations

    • Borgess Heart Institute, Kalamazoo, MI 49048, USA
  • ,
  • Susan Hendrick

      Affiliations

    • Borgess Heart Institute, Kalamazoo, MI 49048, USA
  • ,
  • Carol Moshier

      Affiliations

    • Borgess Heart Institute, Kalamazoo, MI 49048, USA
  • ,
  • Jonathan P. Harwood

      Affiliations

    • Angel Medical Systems, Inc., Tinton Falls, NJ 07701, USA
  • ,
  • Mitchell W. Krucoff

      Affiliations

    • Duke University Medical Center, Durham, NC 27710, USA

Received 5 April 2005 ,Revised 10 May 2005 ,Accepted 10 May 2005.

References 

  1. Heart and Stroke statistical Update. Dallas (Tex): American Heart Association; 1999;
  2. Canto JG, Zalenski RJ, Ornato JP, et al. Use of emergency medical services in acute myocardial infarction and subsequent quality of care observations from the national registry of myocardial infarction 2. Circulation. 2002;106:3018–3023
  3. Ryan TJ, Anderson JL, Antman EM, et al. The physician's role in minimizing pre-hospital delay in patients at high risk for acute myocardial infarction: recommendations from the National Heart Attach Alert Program. Working Group on Educational Strategies to Prevent Prehospital Delay in Patients at High Risk for Acute Myocardial Infarction. Ann Intern Med. 1997;126:645–651
  4. GISSI (Gruppo Italiano per lo Studio della Streptochinasi nel'Infarcto Miocardico). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1986;1:397–402
  5. Second International Study of Infarct Survival (ISIS-2) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17, 187 cases of suspected acute myocardial infarction. Lancet. 1988;2:349–360
  6. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 1993;328:673–679
  7. Gibbons RJ, Holmes DR, Reeder GS, et al. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med. 1993;328:685–691
  8. Faxon D, Lenfant C. Timing is everything: motivating patients to call 9-1-1 at onset of acute myocardial infarction. Circulation. 2001;104:1210–1211
  9. DeLuca G, Suryapranata H, Ottervanger JP, Antman EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction. Every minute counts. Circulation. 2004;109:1223–1225
  10. Brown AL, Mann C, Daya M, et al. Demographic, belief and situational factors influencing the decision to utilize emergency medical services among chest pain patients. Circulation. 2000;102:173–178
  11. Meischke H, Ho MT, Eisenbert MS, et al. Reasons patients with chest pain delay or do not call 911. Ann Emerg Med. 1995;25:193–197
  12. Chew DP, Moliterno DJ, Herrmann HC. Present and potential future paradigms for the treatment of ST-segment elevation acute myocardial infarction. J Invas Cardiol. 2002;14(Suppl A):3A–20A
  13. Luepker RV, Raczynski JM, Osganian S, et al. Effort of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: the Rapid Early Action for Coronary Treatment (REACT) trial. JAMA. 2000;284:60–67
  14. Siegel S, Brodman R, Fischer J, et al. Intracardiac electrode detection of early or subendocardial ischemia. Pacing Clin Electrophysiol. 1982;892–902
  15. Stark KS, Krucoff MW, Schryver B, Kent KM. Quantification of ST-segment changes during coronary angioplasty in patients with left bundle branch block. Am J Cardiol. 1991;67:1219–1222
  16. Herrmann HC, Moliterno DJ, Ohman EM, et al. Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction. Results from the SPEED (GUSTO-4) Pilot) trial. J Am Coll Cardiol. 2000;36:1489–1496
  17. Bush HS, Gerguson JJ, Angelini P, Willerson JT. Twelve-lead electrocardiographic evaluation of ischemia during percutaneous transluminal coronary angioplasty and its correlation with acute reocclusion. Am Heart J. 1991;121:1591–1599

 Disclosures: T.A. Fischell, D.R. Fischell, and R.E. Fischell are cofounders of Angel Medical Systems. J.P. Harwood is a full-time employee of Angel Medical Systems. M. W. Krucoff is a member of the scientific advisory board for Angel Medical Systems.

PII: S1553-8389(05)00061-8

doi: 10.1016/j.carrev.2005.05.002

Cardiovascular Revascularization Medicine
Volume 6, Issue 1 , Pages 14-20 , January 2005